![Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes | World Journal of Surgical Oncology | Full Text Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-018-1325-6/MediaObjects/12957_2018_1325_Fig4_HTML.gif)
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes | World Journal of Surgical Oncology | Full Text
![Case reviews for elevated carcinoembryonic antigen levels with malignancy | Download Scientific Diagram Case reviews for elevated carcinoembryonic antigen levels with malignancy | Download Scientific Diagram](https://www.researchgate.net/publication/334168454/figure/tbl3/AS:776205523488776@1562073226735/Case-reviews-for-elevated-carcinoembryonic-antigen-levels-with-malignancy_Q320.jpg)
Case reviews for elevated carcinoembryonic antigen levels with malignancy | Download Scientific Diagram
![Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. - Abstract - Europe PMC Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4272469/bin/MA-67-397-g007.jpg)
Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. - Abstract - Europe PMC
![Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer](https://www.itmedicalteam.pl/articles-images/annals-clinical-four-tumor-marker-3-3-32-g001.png)
Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer
![Diagnostics | Free Full-Text | Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort Diagnostics | Free Full-Text | Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort](https://www.mdpi.com/diagnostics/diagnostics-10-01036/article_deploy/html/images/diagnostics-10-01036-g001-550.jpg)
Diagnostics | Free Full-Text | Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort
![Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology](https://www.scirp.org/html/1-1900041/e9599858-b3cb-4fff-adab-4bd9f5a04faf.jpg)
Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology
![Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram](https://www.researchgate.net/publication/7660990/figure/fig2/AS:203056043040780@1425423741964/Preoperative-s-CEA-levels-and-disease-free-survival-rate-of-stage-III-colorectal-cancer.png)
Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram
![Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology](https://www.scirp.org/html/1-1900041/a5a809ab-1df3-4755-add6-c3f8629697e9.jpg)
Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology
Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke | PLOS ONE
![The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ] The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7433/1/fig-3-full.png)
The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]
![Tumour biomarkers: association with heart failure outcomes - Shi - 2020 - Journal of Internal Medicine - Wiley Online Library Tumour biomarkers: association with heart failure outcomes - Shi - 2020 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d8c29b76-852d-40fa-95c9-3169593c0865/joim13053-toc-0001-m.jpg)
Tumour biomarkers: association with heart failure outcomes - Shi - 2020 - Journal of Internal Medicine - Wiley Online Library
![Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker](https://coloproctol.org/upload//thumbnails/ac-29-106-i005.jpg)
Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker
![Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker](https://coloproctol.org/upload//thumbnails/ac-29-106-i001.jpg)
Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker
![Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib](https://www.spandidos-publications.com/article_images/etm/2/4/ETM-02-04-0685-g00.jpg)
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
![Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers - Ramona C Dolscheid-Pommerich, Mignon Keyver-Paik, Thomas Hecking, Walther Kuhn, Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers - Ramona C Dolscheid-Pommerich, Mignon Keyver-Paik, Thomas Hecking, Walther Kuhn,](https://journals.sagepub.com/cms/10.1177/1010428317730246/asset/images/large/10.1177_1010428317730246-fig2.jpeg)
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers - Ramona C Dolscheid-Pommerich, Mignon Keyver-Paik, Thomas Hecking, Walther Kuhn,
![Diagnostics | Free Full-Text | Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort Diagnostics | Free Full-Text | Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort](https://pub.mdpi-res.com/diagnostics/diagnostics-10-01036/article_deploy/html/images/diagnostics-10-01036-g001.png?1606989932)